- Report
- February 2024
- 175 Pages
Global
From €4797EUR$5,000USD£4,132GBP
- Report
- February 2024
- 175 Pages
Global
From €4797EUR$5,000USD£4,132GBP
- Report
- January 2024
- 200 Pages
Global
From €4797EUR$5,000USD£4,132GBP
- Report
- January 2024
- 200 Pages
Global
From €4797EUR$5,000USD£4,132GBP
- Report
- October 2023
- 178 Pages
Global
From €4701EUR$4,900USD£4,049GBP
- Report
- February 2024
- 115 Pages
Global
From €4558EUR$4,750USD£3,925GBP
- Drug Pipelines
- April 2024
- 230 Pages
Global
From €2878EUR$3,000USD£2,479GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1919EUR$2,000USD£1,653GBP
- Clinical Trials
- April 2024
- 80 Pages
Global
From €1919EUR$2,000USD£1,653GBP
- Clinical Trials
- April 2024
- 50 Pages
Global
From €1439EUR$1,500USD£1,240GBP
- Report
- March 2024
- 267 Pages
Global
From €7628EUR$7,950USD£6,570GBP
- Report
- November 2023
- 182 Pages
Global
From €4701EUR$4,900USD£4,049GBP
- Drug Pipelines
- July 2023
- 139 Pages
Global
From €10550EUR$10,995USD£9,086GBP
- Report
- May 2018
- 204 Pages
Global
From €2254EUR$2,349USD£1,941GBP
- Report
- June 2018
- 133 Pages
Global
From €600EUR$625USD£517GBP
€1199EUR$1,250USD£1,033GBP
- Report
- May 2024
- 190 Pages
From €3237EUR$3,374USD£2,788GBP
€3597EUR$3,749USD£3,098GBP
- Report
- August 2022
- 111 Pages
Global
From €4558EUR$4,750USD£3,925GBP
- Report
- August 2022
- 117 Pages
Global
From €4318EUR$4,500USD£3,719GBP
- Report
- March 2021
- 75 Pages
Global
€21109EUR$22,000USD£18,181GBP
- Report
- April 2021
- 127 Pages
Global
From €10550EUR$10,995USD£9,086GBP
The Neuroprotective market is a subset of Central Nervous System (CNS) drugs that are designed to protect the brain and spinal cord from damage caused by disease, trauma, or other conditions. Neuroprotective drugs are used to treat a variety of neurological disorders, including stroke, Alzheimer's disease, Parkinson's disease, multiple sclerosis, and traumatic brain injury. These drugs can also be used to reduce the risk of developing these conditions. Neuroprotective drugs work by reducing inflammation, improving blood flow, and protecting neurons from damage.
Neuroprotective drugs are an important part of treating neurological disorders, as they can help reduce the severity of symptoms and improve quality of life. They are also used to prevent further damage to the brain and spinal cord.
Some companies in the Neuroprotective market include AbbVie, AstraZeneca, Biogen, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more